Suchergebnisse - "Rahman, Omar"

PubPharm (59)

11

Gemcitabine-based chemotherapy for advanced biliary tract carcinomas

enthalten in: The Cochrane database of systematic reviews | 2018

von Abdel-Rahman, O. | Elsayed, Z. | Elhalawani, H.

12

Hematological adverse effects in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors : a systematic review and meta-analysis

enthalten in: Breast cancer (Tokyo, Japan) | 2018

von Kassem, L. | Shohdy, K. | Lasheen, S. | +2

13

Radical multimodality therapy for malignant pleural mesothelioma

enthalten in: The Cochrane database of systematic reviews | 2018

von Abdel-Rahman, O. | Elsayed, Z. | Mohamed, H. | +1

14

Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors : a systematic review and meta-analysis

enthalten in: Expert review of anticancer therapy | 2017

von Lasheen, S. | Shohdy, K. | Kassem, L. | +1

15

Risk of Distinctive Hair Changes Associated With Pazopanib in Patients With Renal Cell Carcinoma (RCC) Versus Patients Without RCC : A Comparative Systematic Review and Meta-analysis

enthalten in: Clinical genitourinary cancer | 2017

von Elhalawani, H. | Heiba, M. | Abdel-Rahman, O.

16

External beam radiotherapy for unresectable hepatocellular carcinoma

enthalten in: The Cochrane database of systematic reviews | 2017

von Abdel-Rahman, O. | Elsayed, Z.

17

Development of sorafenib-related side effects in patients diagnosed with advanced hepatocellular carcinoma treated with sorafenib : a systematic-review and meta-analysis of the impact on survival

enthalten in: Expert review of gastroenterology & hepatology | 2017

von Abdel-Rahman, O. | Lamarca, A.

18

Down syndrome in diverse populations

enthalten in: American journal of medical genetics. Part A | 2017

von Kruszka, P. | Porras, A. | Sobering, A. | +41

19

Evaluation of efficacy and safety of different pembrolizumab dose/schedules in treatment of non-small-cell lung cancer and melanoma : a systematic review

enthalten in: Immunotherapy | 2016

von Abdel-Rahman, O.

ErratumIn: Immunotherapy. 2017 Mar;9(4):373. - PMID 28303770

20

Risk of selected gastrointestinal and hepatic toxicities in cancer patients treated with nintedanib : a meta-analysis

enthalten in: Future oncology (London, England) | 2016

von Abdel-Rahman, O. | Bahie Eldin, N. | ElHalawani, H.